Loading...
•
Dec 31, 2023
Pediatrix Q4 2023 Earnings Report
Reported a loss from continuing operations and adjusted EPS from continuing operations.
Key Takeaways
Pediatrix Medical Group reported a net revenue of $496.4 million for Q4 2023, a decrease from $513.8 million in the prior-year period. The company experienced a loss from continuing operations of $124.3 million, or $1.50 per share, compared to an income of $24.0 million, or $0.29 per share, in Q4 2022. Adjusted EPS from continuing operations was $0.32, down from $0.47 in the same period last year. Adjusted EBITDA from continuing operations was $50.8 million, compared to $66.5 million for the prior-year period.
Net revenue for Q4 2023 was $496.4 million, compared to $513.8 million for the prior-year period.
Loss from continuing operations was $124.3 million, or $1.50 per share.
Adjusted EPS from continuing operations was $0.32, compared to $0.47 for the fourth quarter of 2022.
Adjusted EBITDA from continuing operations was $50.8 million, compared to $66.5 million for the prior-year period.
Forward Guidance
Pediatrix anticipates that its 2024 Adjusted EBITDA will be in a range of $200 million to $220 million.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...